{
    "Trade/Device Name(s)": [
        "GluNEO Lite Glucose Monitoring System",
        "GluNEO Lite Professional Glucose Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd",
    "510(k) Number": "K132966",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130181"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "December 5, 2013",
    "Summary Letter Received Date": "September 20, 2013",
    "Submission Date": "September 13, 2013",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (specified) analyte controls",
        "Calculator/data processing module for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GluNEO Lite Meter",
        "GluNEO Lite Professional Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Meter",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for GluNEO Lite and GluNEO Lite Professional Blood Glucose Monitoring Systems for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose in capillary whole blood from multiple body sites (and venous whole blood for Professional version) as an aid for diabetes control; home use (single patient) and professional healthcare settings (multiple patients), not for diagnosis or neonatal use",
    "fda_folder": "Clinical Chemistry"
}